{'fraction_non_alphanumeric': 0.021352313167259787, 'fraction_numerical': 0.0071174377224199285, 'mean_word_length': 5.325842696629214, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
An AP Perspective on Infusion Reactions in the Era of Immunotherapy

As cancer care advances, creative uses for immunotherapy continue to be developed, but it is also important to be cognizant of the risk for infusion reactions. At JADPRO Live Virtual 2021, Carrie Peterson, DNP, RN, AGNP-c, reviewed the different classes and pathophysiology of immunotherapy, how to anticipate potential infusion reactions for each class of immunotherapy, and how to identify and treat infusion reactions during infusion of immunotherapy so that patients can stay on treatment.